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A number of polysaccharides showed good antiviral activity against several animal viruses. At 5 ,Lg/ml,
carrageenan prevented the cell monolayer from destruction by herpes simplex virus type 1 (HSV-1) growth. At
10 ,ug/ml, carrageenan reduced the formation of new infectious HSV-1 by almost five logs. No cytotoxic effects
were detected with concentrations of carrageenan up to 200 ,Lg/ml. When 10 tig of carrageenan per ml was
added at the beginning of HSV-1 infection of HeLa cells, there was potent inhibition of viral protein synthesis,
and the cells continued synthesizing cellular proteins. This did not occur if carrageenan was added 1 h after
HSV-1 infection. The use of [35S]methionine-labeled virions to analyze the entry of HSV-1 or Semliki Forest
virions into cells indicated that carrageenan had no effect on virus attachment or virus entry. Moreover,
carrageenan did not block the early permeabilization of cells to the toxic protein alpha-sarcin. These results
suggest that this sulfated polysaccharide inhibits a step in virus replication subsequent to viral internalization
but prior to the onset of late viral protein synthesis.
Polysaccharides are a complex group of biological mole-
cules (2) known to affect the growth of animal viruses (19).
The routine use of the plaque assay method to titrate animal
viruses soon led to the discovery of inhibitory components in
the agar overlay (20). These components were identified as
sulfated polysaccharides. Plaque production by enceph-
alomyocarditis virus was inhibited in normal agar, whereas a
mutant strain was resistant (22). Addition of a polycation
such as DEAE-dextran counteracted the inhibitory action of
the negatively charged inhibitor (22). Similar findings were
described for poliovirus (23) and coxsackievirus B4 (3).
However, subsequent studies showed that the enhancement
of viral plaques by polycations might not be related to their
interaction with sulfated polysaccharides present in the agar
(25). Heparin also showed a potent inhibitory effect on
herpesvirus replication (16, 24). Since heparin is a polyani-
onic molecule, it was suggested that it would interact with
the positive charges present on the virus or on the cell
surface and inhibit virus attachment (20). In agreement with
this idea, heparin was only active against virus growth when
present during the early stages of viral replication (16).
Prevention of viral attachment by polyanions was reported
by several laboratories (11, 20). However, the method used
to measure virus absorption was crude (4, 11, 13), and the
results obtained require careful interpretation.
Other therapeutically important effects of polysaccharides
have also been reported. For instance, heparin promoted
tumor regression in mice (10). In addition, a number of
natural and synthetic polyanions were also effective inducers
of interferon both in vivo and in vitro (5, 6, 14). Dextran
sulfate also prolonged the incubation period of the scrapie
agent (7). The antiviral effects of some of these compounds
in animals may be a consequence of macrophage activation
or interferon induction or both (5).
In a screening for antiherpes agents with a number of
natural substances, we found that carrageenan had a potent
inhibitory effect against herpes simplex virus type 1 (HSV-1)
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(1). We have now analyzed in more detail the antiviral
properties of this polysaccharide.
MATERIALS AND METHODS
Cells and viruses. Human HeLa cells, baby hamster kid-
ney cells clone 21, mouse fibroblast cells (L929), and green
monkey kidney cells (Vero) were grown in Dulbecco modi-
fied Eagle medium supplemented with 10% newborn calf
serum and containing antibiotics (10,000 IU of penicillin and
50 mg of streptomycin per ml). The maintenance medium
contained only 2% newborn calf serum.
Adenovirus type 5, poliovirus type 1, and vaccinia virus
were grown on HeLa cells. Encephalomyocarditis virus was
grown on L929 cells. Semliki Forest virus, vesicular sto-
matitis virus Indiana strain, HSV-1 KOS strain, HSV-2,
measles virus, and African swine fever virus were grown on
Vero cells. Most of these viruses were originally purchased
from the American Type Culture Collection, Rockville, Md.
Otherwise, HSV-1 was kindly given to us by E. de Clercq
(Louvain, Belgium), vaccinia virus was given by M. Esteban
(New York, N.Y.), and African swine fever virus was given
by E. Tabares (Madrid, Spain). The virus concentration was
estimated by plaque assay on the same cell line as that on
which the virus was grown.
Source of polysaccharides. Polysaccharides were pur-
chased from Sigma Chemical Co., St. Louis, Mo., except
agar, which was from Oxoid Ltd., London, England. Alpha-
sarcin, a toxic protein (molecular weight, 16,800) produced
by Aspergillus giganteus, was a generous gift from D. M.
Schuurmans (Department of Public Health, Lansing, Mich.).
Plaque assay. Confluent cell monolayers were grown on
P60 plates and incubated with 0.5 ml of serial 10-fold
dilutions of virus in phosphate-buffered saline supplemented
with 0.5% calf serum. After an adsorption period of 1 h at
37°C, the inoculum was removed and 5 ml of an overlay of
Dulbecco modified Eagle medium containing 0.6% agar and
2% calf serum was added (adenovirus-incubated cells were
overlaid with Dulbecco modified Eagle medium supple-
mented with 3% fetal calf serum, 25 mM MgC92, 2.5 mM
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arginine, 0.1 mg of DEAE-dextran per ml, and 0.6% agar).
Cell monolayers were incubated at 37°C in a humidified
atmosphere of 6% CO2 in air for several days until a
cytopathic effect was seen. The overlay was removed, the
cell monolayer was precipitated with 5% trichloroacetic
acid, and plaques were counted.
Estimation of cytopathic effect. Monolayers of HeLa cells
were infected with virus at low multiplicity (0.1 to 0.4 PFU
per cell) in the presence of the indicated concentrations of
each polysaccharide. After several virus replication rounds
(24 or 48 h of incubation at 37°C), the cytopathic effects in
infected and uninfected cells were examined under a phase-
contrast microscope. To gain further insight into the cyto-
toxic effects of these compounds, the level of translation was
determined by 1-h incubation with 0.2 ,uCi of [35S]me-
thionine (1,100 Ci/mmol; The Radiochemical Centre,
Amersham, England). Radioactivity of the trichloroacetic
acid-precipitable material was measured in an Intertech-
nique liquid scintillation spectrometer. Each experimental
measurement was carried out in duplicate.
Measurement of production of HSV-1 infectious units.
HeLa cells were grown in 24-well plates and infected with
HSV-1 at 0, 5, or 10 PFU per cell in the presence of various
concentrations of polysaccharide to analyze the reduction of
infectious units in several or one single cycle of replication.
After 48 or 24 h of incubation at 37°C, the medium and the
infected cells were collected and cells were disrupted by
three freeze-thaw cycles. The infectious viruses produced
were estimated by the standard plaque assay.
Effect of polysaccharide on cell proliferation. An average of
3 x 104 HeLa cells per well were seeded in 24-well plates
with Dulbecco modified Eagle medium supplemented with
10% newborn calf serum. Cells were infected with HSV-1 at
a multiplicity of 10 in the presence of 100 p,g of polysaccha-
ride per ml, or were not infected, and were incubated at 37°C
for 4 days. Each day, cells of four wells were trypsinized and
counted with a Neubauer hemacytometer, and the mean
value was calculated.
Measurement of protein synthesis. A 0.2-ml per well
amount of methionine-free medium containing 0.2 ,uCi of
[35S]methionine was added to cells grown on 24-well dishes.
The cell monolayer was incubated at 37°C for 1 h and the
medium was then removed. The cells were fixed with 5%
trichloroacetic acid and washed with ethanol. The fixed cell
monolayer was dried and suspended in 0.2 ml of 0.1 N
NaOH-1% sodium dodecyl sulfate, and incorporated label
was measured as above.
Analysis of proteins by polyacrylamide gel electrophoresis.
HeLa cells grown on 24-well plates were incubated in
methionine-free medium in the presence of 5 ,uCi of
[35S]methionine (1,100 Ci/mmol; The Radiochemical Centre)
per ml for the indicated times. After incubation, the medium
was removed and the cell monolayer was washed with
phosphate-buffered saline. The cells were dissolved in 0.1 ml
of sample buffer (62.5 mM Tris [pH 6.8], 2% sodium dodecyl
sulfate, 0.1 M dithiothreitol, 17% glycerol), sonicated, and
heated to 90°C for 10 min. Samples of 10 1.l were analyzed by
polyacrylamide gel electrophoresis, using 15% acrylamide
gels. The 20-cm-long gels were run overnight at 85 V, and
fluorography was performed with 2,5-diphenyloxazole (20%,
wt/wt). The dried gels were exposed, using XS-5 X-ray films
(Eastman Kodak Co., Rochester, N.Y.).
Radiolabeling and purification of virions. HeLa cells were
grown on 100-mm-diameter dishes. The cell monolayer was
infected with virus at a multiplicity of 10 in Dulbecco
modified Eagle medium supplemented with 2% newborn calf
serum. At 9 h postinfection the medium was replaced with 2
ml of fresh methionine-free medium and 100 ,uCi of
[35S]methionine was added. At 24 h postinfection, the cells
were harvested and disrupted by freezing and thawing. The
cellular extracts were centrifuged at 10,000 rpm for 15 min in
an SS-34 Sorvall rotor. The supernatants were layered onto
3 ml of 50 mM Tris (pH 7.4) with 0.85% NaCl and 30%
sucrose and centrifuged at 40,000 rpm for 3 h in a TY-65
Sorvall rotor. Pellets were suspended in 0.5 ml of Dulbecco
modified Eagle medium supplemented with 2% newborn calf
serum.
Measurement of the entry of virus particles into cells. HeLa
cells grown on 35-mm petri dishes were infected with HSV-1
labeled with [35S]methionine, purified as described above,
and incubated at 37°C. At the indicated times, cell monolay-
ers were washed with saline-phosphate buffer and treated
with 1 ml of saline-phosphate buffer containing 50 mg of
proteinase K (Merck AG) per ml for 15 min at 4°C. The
cells were then washed with saline-phosphate buffer, and
pellets were precipitated with 5% trichloroacetic acid. Ra-
dioactivity retained in GF/C filters was d-etermined in a-liquid
scintillation counter (Intertechnique).
TABLE 1. Effect of polysaccharides on several animal viruses
Polysaccharide Virusa CPE5o
Agar HSV-1 >200
Alginic acid HSV-1 20
Alginic acid (sodium salt) HSV-1 50
Carboxymethyl cellulose HSV-1 >200
Cellulose HSV-1 >200
Chitin HSV-1 >200
Chondroitin sulfate HSV-1 >200
Dextran 500,000 HSV-1 >200
Heparin HSV-1 10
Inulin HSV-1 >200
Starch HSV-1 >200
Iota-carrageenan Ad5 >200
ASF 10
EMC 10
HSV-1 2
HSV-2 10
Measles >200
Polio, type 1 >200
SFV 10
Vaccinia 10
VSV >200
Dextran sulfate 5000 ASF 20
EMC 5
HSV-1 5
Polio, type 1 >200
SFV >200
VSV >200
Dextran sulfate 500,000 HSV-1 1
Polio, type 1 >200
VSV 10
a Ad5, Adenovirus type 5; ASF, African swine fever; SFV, Semliki Forest
virus; VSV, vesicular stomatitis virus; EMC, encephalomyocarditis.
b CPE50, Concentration of compound that conferred 50% protection of the
cytopathic effect. Each value presented was taken from one experiment,
where 10 different concentrations of polysaccharide were tested in replicate
monolayers. None of the polysaccharides screened showed a cytotoxic effect
even at 200 Sjg/ml.
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RESULTS
Antiviral effect of polysaccharides against several animal
viruses. The effects of different polysaccharides on the
growth of several animal viruses are shown in Table 1. The
most active polysaccharides were those that possess sulfated
groups, such as carrageenan, heparin, and dextran sulfate,
although other nonsulfated compounds such as alginic acid
were also active. On the other hand, chondroitin sulfate
(Sigma Chemical Co.) did not protect cells from virus
growth, perhaps because the degree of sulfation of this
polysaccharide is low. Not only were high-molecular-weight
polysaccharides active, but oligosaccharides such as dextran
sulfate (molecular weight, 5,000) also showed good antiviral
activity. As regards the spectrum of action of carrageenan, it
was active against some enveloped viruses such as HSV-1,
HSV-2, and Semliki Forest, vaccinia, and swine fever vi-
ruses. It was without effect against vesicular stomatitis virus
and measles virus. It also had an inhibitory effect against
naked viruses like encephalomyocarditis virus, but it was
devoid of any activity against poliovirus or adenovirus.
These results are more clearly observed in Fig. 1, where the
cytopathic effect and the translation capacity of cells treated
with carrageenan are analyzed. In general, there is agree-
ment between the results obtained on the prevention of the
cytopathic effect and the prevention of the translation ca-
pacity of the cell monolayer. It is noteworthy that 200 ,ug of
carrageenan per ml had no deleterious effects on uninfected
cells as observed by phase-contrast microscopy or by mea-
suring the capacity of the cells to incorporate [35S]me-
thionine into protein after 2 days of incubation with the
polysaccharide. On the other hand, 10 ,ug of carrageenan per
ml fully protected against the destruction of the cell mono-
layer by HSV-1 growth. More detailed studies with lower
concentrations of carrageenan have shown that 50% protec-
tion of the cytopathic effect against HSV-1 corresponds to 2
,ug/ml. Keeping in mind that the average molecular weight of
carrageenan is 500,000, this gives an average concentration
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FIG. 1. Protection of the cytopathic effect of HeLa cells infected
with different viruses in the presence of the indicated concentrations
of carrageenan (A and B). Protein synthesis was measured in
virus-infected cells and in control uninfected cells (C and D). SFV,
Semliki Forest virus; EMC, encephalomyocarditis virus; VSV,
vesicular stomatitis virus; ASF, African swine fever virus.
6.0
-407E
CL
US
0
2.0
z
0
u
cn
D 6.0
)r
4.0
A
,I.. . t
O 10 50 100 20C
CARRAGEENAN (pjg/mi)
0 6 12 18 24
TIME (h.p.i )
FIG. 2. Effect of carrageenan on production of infectious virus.
(A) Production of PFU of HSV-1 in infected HeLa cells treated with
carrageenan from the beginning of infection. Cells were collected
and PFU were evaluated by the standard plaque assay on Vero cells.
Symbols: 0, PFU production during a single round of replication at
a multiplicity of 10 PFU per cell; A, PFU production during several
rounds of replication at a multiplicity of 0.5 PFU per cell. (B) Time
dependence of carrageenan (100 ,ug/ml) addition to HSV-1-infected
HeLa cells. Production of PFU was evaluated by the standard
plaque assay on Vero cells. p.i., Postinfection.
of 4 x 10-9 M. The antiviral index for carrageenan is above
100 as defined by the concentration of the compound that
would produce a 50% inhibition of cell growth (>200 ,ug/ml)
divided by the concentration that confers 50% protection of
the cytopathic effect (<2 ,ug/ml).
Effect of carrageenan on HSV-1 and cell growth. The
reduction of HSV-1 growth by carrageenan is shown in Fig.
2. As little as 10 ,ug of carrageenan per ml profoundly inhibits
the production of infectious HSV-1 either in a single cycle or
in
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FIG. 3. Effect of carrageenan on cell proliferation. HeLa cells
were seeded at a concentration of 3 x 104 cells per well. They were
mock infected and incubated at 37°C in the absence (0) or presence
(0) of 100 ,ug of carrageenan per ml, or they were infected with
HSV-1 at a multiplicity of 10 PFU per cell in the absence (A) or
presence (A) of 100 ,ug of carrageenan per ml. p.i., Postinfection.
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FIG. 4. Polyacrylamide gel electrophoresis of the proteins synthesized in HSV-1-infected HeLa cells at several times postinfection (p.i.)
in the absence (-) or presence of 100 p.g of carrageenan per ml added from the beginning of infection (0) or 1 h postinfection (1).
in several rounds of replication (Fig. 2A). The time of
addition of carrageenan is very important, because the
compound is most active when added at the very early stages
of virus growth and has only a marginal effect when added
after h 4 of HSV-1 infection (Fig. 2B). We have also
observed that pretreatment of cells with carrageenan does
not confer protection against HSV-1 and does not show
direct virucidal effects (results not shown).
As described above, carrageenan has no effect on cell
morphology or on the capacity of the cells to synthesize
proteins after 2 days of incubation (Fig. 1). To further test
the toxicity of carrageenan to culture cells, the inhibition of
cell proliferation was measured. Figure 3 shows that HeLa
cells seeded at low concentration grow at control levels in
the presence of 100 p.g of carrageenan per ml. Moreover,
even HSV-1-infected cells are able to proliferate in the
presence of the polysaccharide, suggesting that carrageenan
allows HSV-1-infected cells to survive (Fig. 3).
Antiherpes mechanism of action of carrageenan. To ascer-
tain the effect of carrageenan on protein synthesis in HSV-
1-infected cells, the experiment shown in Fig. 4 was done.
HeLa cells were infected with HSV-1 and carrageenan was
added immediately or 1 h after HSV-1 infection. Protein
synthesis was then analyzed at various times after infection.
When carrageenan was present from the very beginning of
infection, viral proteins were not detected, whereas if car-
rageenan was added 1 h after HSV-1 infection late viral
proteins were apparent. These results demonstrate that
carrageenan must be present from early times to exert its
antiherpes activity and that the step blocked by this poly-
saccharide in viral replication is prior to the synthesis of late
viral proteins. The concentration dependence of carrageenan
on the inhibition of viral protein synthesis showed that some
viral proteins still appeared at 5 Vig of carrageenan per ml,
and virtually no viral proteins were detected at concentra-
tions above 20 p.g/ml (results not shown). Therefore, we
routinely used 100 p.g of carrageenan per ml in our subse-
quent experiments.
Previous studies from other laboratories indicated that
sulfated polysaccharides inhibited virus attachment to the
cell surface (20). To investigate this possibility, HSV-1
virions were labeled with [35S]methionine and virus entry
into cells was measured in the absence or presence of
carrageenan. To our surprise, no inhibition of virus internal-
ization was observed even in the presence of 100 pg of
carrageenan per ml (Fig. 5A), suggesting that this polysac-
charide blocked a step in virus replication subsequent to
virus attachment and entry. This result is in good agreement
with our finding that increased internalization of [3H]heparin
occurs during HSV-1 entry into cells (Gonzalez and Car-
rasco, unpublished results). Therefore, it seems reasonable
to suggest that viral particles and the polysaccharide are
cointernalized in endosomes. The polymer may inhibit a step
in virus replication occurring between virus release from
pinocytotic vesicles and the synthesis of late proteins.
During virus entry the infected cells become permeabil-
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FIG. 5. Effect of carrageenan on (A) entry of HSV-1 into HeLa cells and (B) early cell permeability induced by HSV-1. (A)
[35S]methionine-labeled HSV-1 was purified as described in Materials and Methods. Radiolabeled virus at 120,000 cpm was added to HeLa
cells in the presence (A) of 100 ,ug of carrageenan per ml or in the absence (A) of the polysaccharide. Virus entry into cells at 37°C was
measured as described in Materials and Methods. Background of entry was determined by the addition of [35S]methionine-labeled HSV-1 to
cells in the absence (0) or presence (0) of the compound at 4°C. (B) HeLa monolayers were infected with HSV-1 at a multiplicity of infection
of 100 in the presence of 100 ,ug of carrageenan per ml and different concentrations of alpha-sarcin. After 1 h of incubation at 37°C, the cell
monolayers were washed three times, and 1 h later protein synthesis was estimated as described in Materials and Methods. Symbols: 0,
uninfected control cells; 0, uninfected cells treated with carrageenan; A, HSV-1-infected control cells; A, HSV-1-infected cells treated with
carrageenan.
ized to proteins such as alpha-sarcin (8) or Pseudomonas
toxin (9). Carrageenan did not inhibit this process (Fig. SB),
further reinforcing the idea that virus attachment and entry
are not the steps blocked by sulfated polysaccharides.
To determine whether carrageenan must be present to-
gether with HSV-1 virion particles to prevent viral protein
synthesis, cells were infected with HSV-1 in the absence or
presence of 100 ,ug of carrageenan per ml. After 0.5 h of
incubation, the excess virus and polysaccharide were re-
moved from the culture medium and some cultures were
further superinfected with HSV-1. In agreement with previ-
ous results, when the cells are infected with HSV-1 in the
presence of carrageenan no viral proteins appear even after
18 h postinfection (data not shown). However, if the cells
have been pretreated with the compound or with the com-
pound plus herpes virions, there is no inhibition of a subse-
quent infection by HSV-1.
DISCUSSION
Polysaccharides were found to be potent antiviral agents,
but the antiviral effects of these compounds were not pur-
sued perhaps for two reasons: (i) they are high-molecular-
weight components, and it is unlikely that they pass the
different barriers of the body or even the cell membrane; and
(ii) it was thought that they blocked viral attachment, an
"unrewarding step in antiviral chemotherapy" (19).
Although it is unlikely that large polysaccharides can
penetrate the skin for topical use against certain cutaneous
HSV-1 infections, it is possible that small oligosaccharides
such as dextran sulfate 5000 pass those barriers easier. In
fact, oligosaccharides are found in the blood when rats are
fed with oral heparin, suggesting that these compounds are
much more difusible in the body than previously thought
(12). In agreement with previous findings (17), our studies
suggest that antivirally inert polysaccharides such as dex-
trans become active when sulfate groups are present in the
molecule. This opens the possibility of using rather inexpen-
sive oligosaccharides, which are abundant in nature, and
converting them by a simple reaction into antiviral com-
pounds. We do not yet know if the presence of other groups
in the molecule other than sulfate also confer the biological
activity reported in this work.
Polysaccharides are thought to inhibit the very early step
of viral replication, i.e., virus attachment to the cell surface
(19). In agreement with this idea, our results indicate that
viral protein synthesis is prevented by carrageenan, and this
inhibition is observed only when the compound is present
during virus entry. However, in contrast with the suggestion
that sulfated polysaccharides inhibit virus attachment, our
findings with labeled virion particles clearly indicate that
virions are internalized at control levels, even with concen-
trations of carrageenan 10 times greater than those necessary
to block viral replication. It must be emphasized that the
suggestion that sulfated polysaccharides inhibit virus ad-
sorption (20) was based on a rather crude test. Briefly, the
experiment consisted of the incubation of cells with viruses
in the presence of the polysaccharide followed by the
washing away of the inhibitor. Afterwards, the cells were
overlaid with agar and incubated to count viral plaques. A
reduction in the number of viral plaques was taken as
evidence of inhibition of virus attachment. Our results
indicating that there is virus internalization but that a sub-
sequent step in viral replication is blocked even if car-
rageenan is washed out (not shown) are in agreement with
these early findings but indicate that their interpretation was
not wholly correct.
Since HSV-1 was still able to permeabilize cells to alpha-
sarcin, a process thought to be mediated by the perme-
abilization of pinocytotic vesicles (15), the possibility exists
that virions are released from those vesicles even in the
presence of the inhibitor. If this were so, those virions would
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be either unable to decapsidate or unable to fully express
their genomes, since no late viral proteins appear in the
presence of carrageenan.
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